• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

职业性胆管癌的多阶段致癌作用:克隆扩增的影响及风险评估

Multistage carcinogenesis in occupational cholangiocarcinoma: the impact of clonal expansion and risk estimation.

作者信息

Watanabe Masahiko, Haeno Hiroshi, Mimaki Sachiyo, Tsuchihara Katsuya

机构信息

School of Pharmacy, Shujitsu University, 1-6-1 Nishigawara, Okayama, 703-8516, Japan.

Research Institute for Biomedical Sciences, Tokyo University of Science, 2669 Yamazaki, Noda, Chiba, 277-0022, Japan.

出版信息

Genes Environ. 2024 Oct 24;46(1):21. doi: 10.1186/s41021-024-00315-7.

DOI:10.1186/s41021-024-00315-7
PMID:39444007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11515581/
Abstract

BACKGROUND

Both mutation induction and clonal expansion of mutated cells cause cancer. The probability of cancer development depends on mutations, clonal growth rates, and carcinogenic mechanisms. A recent study showed cases of occupational cholangiocarcinomas that originate multifocally, with higher mutation burden levels than those in common cholangiocarcinomas. This study aimed to identify the effect of clonal expansion on and estimate the risk of occupational and common intrahepatic cholangiocarcinomas (ICCs) using a multistage model modified to include the effect of cell expansion at any carcinogenic stage.

METHODS

The age-specific incidence of common ICC estimated from the Vital Statistics in Japan and the prognosis of ICC, and mutation frequencies of occupational and common ICC available from the previous report, were applied to a multistage model modified with cell proliferation effects. From the fittest model, the risk after exposure was estimated.

RESULTS

The required number of stages for carcinogenesis was estimated to be three based on the incidences and mutation frequencies of occupational and common ICCs. Based on this estimation, the predicted incidence curve under the model was similar to that estimated from the ICC mortality rate, except for older adults. The model indicated a minor effect of clonal expansion on the observed occupational ICC risk. It predicted a rapid decrease in ICC risk after the cessation of occupational exposure, although the time of clinical detection of cancer after the exposure was affected by latency. The model predicted an increase in cancer risk in older adults caused by cell expansion and common background mutations. However, the risk in older adults was overestimated in the case of common ICC; this divergence could influence occupational ICC cases.

CONCLUSIONS

Three-stage ICC carcinogenesis has been proposed. The high mutation burden levels caused by occupational exposure led to an immediate incidence of cancer. After a long period of relatively low cancer risk, an increased risk in older adults was also predicted.

摘要

背景

突变诱导和突变细胞的克隆扩增均会引发癌症。癌症发生的概率取决于突变、克隆生长速率和致癌机制。最近一项研究显示,职业性胆管癌病例多灶起源,其突变负担水平高于普通胆管癌。本研究旨在使用一个经过修改的多阶段模型来确定克隆扩增对职业性和普通肝内胆管癌(ICC)的影响,并估计其风险,该模型纳入了任何致癌阶段细胞扩增的影响。

方法

将根据日本生命统计数据估算的普通ICC的年龄别发病率、ICC的预后情况,以及先前报告中可得的职业性和普通ICC的突变频率,应用于一个经过细胞增殖效应修改的多阶段模型。从最适合的模型中,估计暴露后的风险。

结果

根据职业性和普通ICC的发病率及突变频率,估计致癌所需的阶段数为三个。基于这一估计,该模型下预测的发病率曲线与根据ICC死亡率估计的曲线相似,但老年人除外。该模型表明克隆扩增对观察到的职业性ICC风险影响较小。它预测职业暴露停止后ICC风险会迅速下降,尽管暴露后癌症的临床检测时间受潜伏期影响。该模型预测老年人因细胞扩增和常见背景突变导致癌症风险增加。然而,在普通ICC的情况下,老年人的风险被高估了;这种差异可能会影响职业性ICC病例。

结论

已提出ICC致癌为三阶段过程。职业暴露导致的高突变负担水平导致癌症立即发病。在经历了较长时期相对较低的癌症风险后,预计老年人的风险也会增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/ad44a13fb036/41021_2024_315_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/e9a4f03e2e13/41021_2024_315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/9460f117f109/41021_2024_315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/4bcf68ec6bfc/41021_2024_315_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/7dcc684113c6/41021_2024_315_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/d4fd6f163aac/41021_2024_315_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/465cb437f71d/41021_2024_315_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/ad44a13fb036/41021_2024_315_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/e9a4f03e2e13/41021_2024_315_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/9460f117f109/41021_2024_315_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/4bcf68ec6bfc/41021_2024_315_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/7dcc684113c6/41021_2024_315_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/d4fd6f163aac/41021_2024_315_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/465cb437f71d/41021_2024_315_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8b2/11515581/ad44a13fb036/41021_2024_315_Fig7_HTML.jpg

相似文献

1
Multistage carcinogenesis in occupational cholangiocarcinoma: the impact of clonal expansion and risk estimation.职业性胆管癌的多阶段致癌作用:克隆扩增的影响及风险评估
Genes Environ. 2024 Oct 24;46(1):21. doi: 10.1186/s41021-024-00315-7.
2
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.肝内胆管癌的空间和时间克隆进化。
J Hepatol. 2018 Jul;69(1):89-98. doi: 10.1016/j.jhep.2018.02.029. Epub 2018 Mar 16.
3
S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.S100P 免疫组化染色可识别出具有与肝门部和肝外胆管细胞癌相似形态学和分子特征的外周型肝内胆管细胞癌亚群。
Histopathology. 2012 Dec;61(6):1106-16. doi: 10.1111/j.1365-2559.2012.04316.x. Epub 2012 Aug 8.
4
Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients.PTPN3 中的激活突变促进胆管癌细胞增殖和迁移,并与患者肿瘤复发相关。
Gastroenterology. 2014 May;146(5):1397-407. doi: 10.1053/j.gastro.2014.01.062. Epub 2014 Feb 4.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.全球范围内 1993 年至 2012 年内肝内和肝外胆管癌发病率的变化趋势。
Cancer. 2020 Jun 1;126(11):2666-2678. doi: 10.1002/cncr.32803. Epub 2020 Mar 4.
7
KRAS mutation in intrahepatic cholangiocarcinoma: Linkage with metastasis-free survival and reduced E-cadherin expression.肝内胆管癌中的 KRAS 突变:与无转移生存期相关,并降低 E-钙黏蛋白表达。
Liver Int. 2022 Oct;42(10):2329-2340. doi: 10.1111/liv.15366. Epub 2022 Jul 25.
8
Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.肝细胞癌合并胆管癌和肝内胆管癌的全外显子突变和转录组全景揭示了分子多样性。
Biochim Biophys Acta Mol Basis Dis. 2018 Jun;1864(6 Pt B):2360-2368. doi: 10.1016/j.bbadis.2018.01.027. Epub 2018 Feb 1.
9
Comparison of clinicopathological characteristics between patients with occupational and non-occupational intrahepatic cholangiocarcinoma.职业性与非职业性肝内胆管癌患者临床病理特征的比较。
J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):389-96. doi: 10.1002/jhbp.353. Epub 2016 May 3.
10
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by F-FDG-PET is associated with the KRAS mutation status and prognosis.术前 F-FDG-PET 测量的肝内胆管细胞癌代谢肿瘤体积与 KRAS 突变状态和预后相关。
J Transl Med. 2018 Apr 11;16(1):95. doi: 10.1186/s12967-018-1475-x.

本文引用的文献

1
Why cancer risk declines sharply in old age.为何癌症风险在老年时会急剧下降。
Nature. 2024 Jul;631(8020):261-262. doi: 10.1038/d41586-024-02107-z.
2
Computational modeling of locoregional recurrence with spatial structure identifies tissue-specific carcinogenic profiles.具有空间结构的局部区域复发的计算模型可识别组织特异性致癌特征。
Front Oncol. 2023 Apr 6;13:1116210. doi: 10.3389/fonc.2023.1116210. eCollection 2023.
3
Integration of quantitative methods and mathematical approaches for the modeling of cancer cell proliferation dynamics.
整合定量方法和数学方法,用于癌症细胞增殖动力学的建模。
Am J Physiol Cell Physiol. 2023 Feb 1;324(2):C247-C262. doi: 10.1152/ajpcell.00185.2022. Epub 2022 Dec 12.
4
Nivolumab for treating patients with occupational cholangiocarcinoma.尼伏单抗治疗职业性胆管癌患者。
J Hepatobiliary Pancreat Sci. 2022 Nov;29(11):1153-1155. doi: 10.1002/jhbp.1215. Epub 2022 Aug 8.
5
Delineating the evolutionary dynamics of cancer from theory to reality.描绘癌症从理论到现实的进化动力学。
Nat Cancer. 2020 Jun;1(6):580-588. doi: 10.1038/s43018-020-0079-6. Epub 2020 Jun 22.
6
Mathematical Modeling of Locoregional Recurrence Caused by Premalignant Lesions Formed Before Initial Treatment.初始治疗前形成的癌前病变所致局部区域复发的数学建模
Front Oncol. 2021 Oct 13;11:743328. doi: 10.3389/fonc.2021.743328. eCollection 2021.
7
Declining Cancer Incidence in the Elderly: Decreasing Diagnostic Intensity or Biology?老年人癌症发病率下降:诊断强度降低还是生物学因素?
Cancer Epidemiol Biomarkers Prev. 2022 Jan;31(1):280-286. doi: 10.1158/1055-9965.EPI-21-0797. Epub 2021 Oct 18.
8
Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.胆道癌青年患者的危险因素和特征:日本肝胆胰外科学会胆道外科项目研究的结果。
J Hepatobiliary Pancreat Sci. 2020 Sep;27(9):571-580. doi: 10.1002/jhbp.776. Epub 2020 Jul 30.
9
Immunosuppressive tumor microenvironment in occupational cholangiocarcinoma: Supportive evidence for the efficacy of immune checkpoint inhibitor therapy.职业性胆管癌中的免疫抑制性肿瘤微环境:免疫检查点抑制剂治疗疗效的支持证据。
J Hepatobiliary Pancreat Sci. 2020 Nov;27(11):860-869. doi: 10.1002/jhbp.788. Epub 2020 Jul 20.
10
Multiple cholangiocarcinomas in the intrahepatic and extrahepatic biliary tree due to dichloromethane exposure: a case report.因接触二氯甲烷导致肝内和肝外胆管树多发胆管癌:一例报告
Surg Case Rep. 2020 Apr 21;6(1):79. doi: 10.1186/s40792-020-00842-9.